General Motors, 3M, and pharma companies beef up lobbying firepower amid coronavirus pandemic
WASHINGTON — General Motors and 3M, two major corporations that have feuded publicly with President Trump in recent weeks, are adding additional lobbying firepower.
Their new spending in Washington, along with similar increases from other companies on the frontlines of the U.S. response, comes as lawmakers and the Trump administration increasingly lean on companies to develop drugs, manufacture masks, and assemble ventilators.
